Armata Pharmaceuticals (ARMP) Treasury Shares (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Treasury Shares of $135000.0 for Q1 2026, down 11.48% sequentially from $152500.0 in Q4 2025, and down 33.33% YoY from $202500.0 in Q1 2025.
Armata Pharmaceuticals (ARMP) Treasury Shares (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Treasury Shares for 13 years, with the latest figure at $135000.0 in Q1 2026.
- Quarterly Treasury Shares fell 33.33% year-over-year to $135000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $135000.0 (down 33.33% YoY) and the FY2025 annual result came in at $152500.0, down 30.68% from the prior year.
- Treasury Shares declined to $135000.0 in Q1 2026 per ARMP's latest filing, from $152500.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $290000.0 in Q1 2024 and troughed at $9748.0 in Q3 2022.
- A 5-year average of $158948.1 and a median of $152500.0 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares tumbled 93.67% in 2022, then surged 2874.97% in 2024.
- Over 5 years, Treasury Shares stood at $129666.0 in 2022, then soared by 54.24% to $200000.0 in 2023, then climbed by 10.0% to $220000.0 in 2024, then sank by 30.68% to $152500.0 in 2025, then fell by 11.48% to $135000.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $135000.0, $152500.0, and $152500.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 135,000.00 |
| Jun 30, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | 152,500.00 |
| Dec 31, 2025 | 152,500.00 |
| Sep 30, 2025 | 152,500.00 |
| Sep 30, 2025 | 152,500.00 |
| Jun 30, 2025 | 202,500.00 |
| Jun 30, 2025 | 202,500.00 |
| Mar 31, 2025 | 202,500.00 |
| Mar 31, 2025 | 202,500.00 |
| Dec 31, 2024 | 220,000.00 |
| Dec 31, 2024 | 220,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |